"To join Boehringer Ingelheim was the best ever decision"

Michael Mark, a pharmacologist, joined our company in 1985. He has played a key role in the research and development of several medications. To date, he has improved the lives of millions of patients. 

Together with Mark, we went back to his former university to reflect on his remarkable career. Watch our video to learn how it feels to see a product that you have developed in a pharmacy – and what he thinks about our company, five years after he retired.
 

If you want to work with us and make a difference, check our job opportunities and Boehringer Ingelheim Careers in research & development. 

About the video:

Mark was just 28 years old and had just received his PhD in pharmacology from the University of Tübingen when he joined the Karl Thomae GmbH in Biberach, a long-standing partner and part of Boehringer Ingelheim since 1993, on July 1, 1985.

He remained with Boehringer Ingelheim until his retirement in 2019. Mark worked for us for 34 years, including 19 years as Head of CardioMetabolic Diseases Research. He played a key role in the research and development of several drugs. To date, he has improved the lives of millions of patients.

"Boehringer Ingelheim is a fascinating place for scientists"

“From a pharmacist's view, it's really a dream to now see a medication in a public pharmacy where I can hint to and say, well, I was part of the team who worked on that medication”, he says in the video.

And: “Now being retired, looking back, I must say Boehringer Ingelheim is a fascinating and the best place for researchers. I never dreamed about the other parts of the world, but being part of Boehringer Ingelheim means also to be part of global teams.” He summarizes: “It's never a single person you should award and recognize, but it's always a team.”